Key Summary
- From September 2026, pharmacist fees will rise to £310 (+£17), technician fees to £146 (+£8), and premises fees to £441 (+£25).
- The GPhC justified the hike by citing a 77 percent increase in public concerns and a 60 percent rise in pharmacy inspections since 2023-24.
- Despite 84 percent of 3,166 respondents disagreeing with the proposal, the council voted to proceed to avoid further operational deficits.
The General Pharmaceutical Council (GPhC) has officially confirmed a six percent increase in renewal fees for the 2026-27 financial year.
The decision, made during a council meeting on March 26, marks the second stage of a multi-year fee arrangement first proposed in early 2025.
Starting in September 2026, the annual cost for a pharmacist to remain on the register will increase by £17 to a total of £310. Pharmacy technicians will see an £8 rise to £146, while the fee for pharmacy premises will jump by £25 to £441.
This follows a consultation in early 2025 on plans for a first six per cent fee increase in September 2025 to be followed by an increase of the same proportion the following September as part of GPhC's the first multi-year fee arrangement.
Justifying the increase, the GPhC said it is facing a huge rise in its casework, with concerns raised by the public up 77 percent since 2023-24 and pharmacy inspection activity up 60 percent over the same period.
The GPhC warned that failing to implement a round of fee increases in September would “extend the deficits we have experienced in recent years and undermine our ability to regulate effectively.”
It added that while it is committed to making savings it has seen operational costs such as utility bills and employment costs go up.
However, the move faces significant friction from the profession. Of the 3,166 responses to the 2025 consultation, 84 percent disagreed with the hike. Critics argued that the increase would further damage workplace morale and noted that pharmacists already pay higher fees relative to their salaries compared to doctors or nurses.
GPhC chief executive Duncan Rudkin said: “We understand that these proposed fee increases come at a time when many people within pharmacy are experiencing increased financial pressures. But we believe that the fee increases we are proposing are necessary so that we can fulfil our statutory duties and provide assurance to the public.
“We are currently in deficit and our financial projections show that this will remain and increase over the next five years. This is not sustainable, and alongside measures we are taking to reduce expenditure and lower our reserves; it leaves us with no alternative but to raise our fees.
